GSK3B and colorectal carcinoma: Collectively, GSK3β could reduce the expression of MZF1 through restraining FTO expression and thus lead to a decrease in the c‐MYC expression, thus inhibiting the proliferative and migratory phenotypes of CRC cells while promoting their apoptosis.